Tekla Life Financials

XHQLX Fund  USD 14.61  0.12  0.83%   
You can harness fundamental analysis to find out if Tekla Life Sciences is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to break down and interpolate three available drivers for Tekla Life Sciences, which can be compared to its competition. The fund experiences a moderate upward volatility. Check odds of Tekla Life to be traded at $16.07 in 90 days.
  
Please note that you must use caution to infer results of funds future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.

Tekla Life Fund Summary

Tekla Life competes with Voya Target, Voya Target, Pro-blend(r) Moderate, Transamerica Cleartrack, and Great-west Moderately. Tekla Life is entity of United States. It is traded as Fund on NMFQS exchange.
Specialization
null, Health
InstrumentUSA Mutual Fund View All
ExchangeNMFQS Exchange
BenchmarkDow Jones Industrial
CurrencyUSD - US Dollar

Tekla Life Key Financial Ratios

Tekla Life Sciences Systematic Risk

Tekla Life's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tekla Life volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Tekla Life Sciences correlated with the market. If Beta is less than 0 Tekla Life generally moves in the opposite direction as compared to the market. If Tekla Life Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tekla Life Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tekla Life is generally in the same direction as the market. If Beta > 1 Tekla Life moves generally in the same direction as, but more than the movement of the benchmark.

Tekla Life March 14, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Tekla Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tekla Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tekla Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Tekla Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tekla Life's daily price indicators and compare them against related drivers.

Other Information on Investing in Tekla Mutual Fund

Tekla Life financial ratios help investors to determine whether Tekla Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tekla with respect to the benefits of owning Tekla Life security.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios